Bactana Animal Health

Bactana Animal Health is a global development stage animal health company. Its product development platform (FPS-4) is initially being developed for food animals and has demonstrated increases in yield efficiency, weight gain, and improved gut health through enhancement to an animal’s microbiome.

Fitzroy Salute, LLC

Fitzroy Salute, LLC offers an affordable and comprehensive environmental health and safety information management solution to streamline and improve EHS operations. The cloud-based IMS provides environmental health and safety staff with integrated modules for hazard assessment, safety and compliance, metric tracking, and more. Fitzroy Salute, LLC provides academic and healthcare institutions the tools they need to foster a true culture of safety, rather than just compliance.

Adepa Biosciences

Adepa Biosciences (formerly Vernx Biotechnology) is developing a range of nutrition products using branched fatty acids (BCFA) for multiple uses: to improve gastrointestinal health in pre-mature and non-premature infants, as a nutritional supplement for adults, and for eventual therapeutic use.

Computational Textiles

Computational Textiles, Inc is a small employee-owned company founded to create textile visualization and manufacturing software. The company’s first product, Weft, is a web application and manufacturing process that enables anyone to transform design ideas into intricately patterned woven cloth.

AffyImmune Therapeutics

AffyImmune is an immuno-oncology company that develops T cell products for cancer therapy. The company was founded based on intellectual property generated from Weill Cornell Medicine that enables imaging of T cells in patients and T cells to specifically target tumors. The company has two products in the pipeline, and are ready to commence clinical trials in 2018

Esper BioSciences, Inc.

Esper Biosciences aims to develop a low-cost, high-speed DNA sequencer, for use in point-of-care medical diagnostics and scientific research.

Airy3D, Inc.

Airy3D is a consumer electronic company developing a suite of passive depth recovery technologies to bring 3D machine vision to any camera. The company raised $10 million of Series A venture funding in 2018. The funding was used to advance its licensing roadmap for the first commercial adoptions of its DepthIQTM 3D sensor platform with top-tier mobile OEMs (original equipment manufacturers). Airy3D has raised $14M in venture capital funding to date.

Fesarius Therapeutics, Inc.

Fesarius Therapeutics is developing engineered tissue scaffold products for the skin and dermal layers. The products are based off the patent-pending microstructure-containing gel scaffold technology developed at Cornell. The acellular skin replacement will aim to benefit those with wounds resulting from burns, plastic surgery, tumor removal, and other forms of trauma. The company joined the National Institutes of Health as part of its I-Corps @ NIH Winter 2020 Program in February 2020.

Annapurna Therapeutics Limited

Annapurna Therapeutics is a gene therapy company focused on discovering and developing new therapeutic products for people living with severe diseases. Annapurna’s product pipeline includes programs for alpha-1 antitrypsin (A1AT) deficiency, hereditary angioedema (HAE), the cardiomyopathy associated with Friedreich’s ataxia and severe allergy. Annapurna Therapeutics was acquired by Avalanche Biotechnologies, Inc. in 2016.

XyloCor Therapeutics, Inc.

XyloCor is a clinical-stage biotechnology company dedicated to developing first-in-class gene therapies for patients with cardiovascular disease. The company’s lead product comprises the use of vascular endothelial growth factor for the treatment of diffuse coronary artery disease.